Next Generation Sequencing Market Research Reports & Industry Analysis
The next generation sequencing (NGS) industry is altering our understanding of genetics and leading to advancements in healthcare, agriculture, and other critical areas. NGS market growth is being driven by decreasing cost, rapid turnaround times, and the rise of high throughput sequencing, with the power to facilitate large-scale population studies, microbiome research, and cancer genomics. MarketResearch.com provides a collection of next generation sequencing industry reports to help you navigate this evolving landscape and gain in-depth insights.
Next Generation Sequencing Market Analysis
- Drawing on extensive primary and secondary research, our reports provide expert market analysis, company profiles, and strategic recommendations.
- We explain how the next generation sequencing market is evolving, and how you can ensure you are at the forefront of the market.
- In addition, our research pinpoints the most lucrative areas of the market, so you can capitalize on them at the right time.
A Research Partner You Can Trust
With more than two decades of experience in the field, MarketResearch.com has long served a range of clients including leading investment banks, management consulting firms, and Fortune 500 multinational corporations. We collect reports from hundreds of leading firms to create a convenient source of insights accessible through a single platform. Each step of the way, our dedicated research specialists are available to offer expert guidance and recommendations.
Next Generation Sequencing Industry Research & Market Reports
-
Global Clinical Next Generation Sequencing (NGS) Market Size, Growth, Share, Trends and Forecasts 2025 – 2032
... billion by 2032, registering a CAGR of 13.6% over the forecast period of 2025 to 2032 Global Clinical Next Generation Sequencing (NGS) Market Growth Drivers Next Generation Sequencing (NGS) has revolutionized the field of genomics, ... Read More
-
The 2026-2031 World Outlook for Clinical Oncology Next Generation Sequencing
... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More
-
The 2026-2031 World Outlook for Long Read Sequencing
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for RNA Analysis and Transcriptomics Microarrays
... country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using ... Read More
-
Global Metagenomic Sequencing Market - 2025-2033
... metagenomic sequencing market is poised for substantial growth driven by the rising focus on microbiome research and technological advancements in sequencing. The key trends shaping the metagenomic sequencing market are growing emphasis in clinical diagnostics, ... Read More
-
HLA Typing Market by Technology (PCR (SSO, SSP, Real-time), Sequencing (NGS, Sanger's)), Product (Instruments, Reagents, Software), Application (Donor-recipient Cross-matching, Transfusion, Cancer), End User (Hospitals, Reference Labs) Global Forecasts to 2030
... 2025 to 2030. Transplantation continues to be the preferred treatment option for many patients suffering from chronic dialysis-dependent end-stage renal disease, as well as those requiring heart, liver, or bone marrow transplants. Over the past ... Read More
-
mRNA Vaccines and Therapeutics Market Report by Vaccine Type (Self-amplifying mRNA-Based Vaccines, Conventional Non-Amplifying mRNA-Based Vaccines), Treatment Type (Bioengineered Vaccine, Gene Therapy, Gene Transcription, Cell Therapy, Monoclonal Antibody, and Others), Vaccine Manufacturing (In-House, Out-Sourced), Application (Cancer, Infectious Disease, Gene Editing, Protein Replacement), End-User (Hospitals and Clinics, Research Organizations, and Others), and Region 2025-2033
... during 2025-2033. The development and acceptance of mRNA-based vaccines on a global scale, the growing need for quick and adaptable solutions for emerging and re-emerging infectious diseases, and the increasing incidence of cancer and genetic ... Read More
-
Single-Cell Genome Sequencing
... at a CAGR of 13.6% over the analysis period 2024-2030. Instruments, one of the segments analyzed in the report, is expected to record a 14.2% CAGR and reach US$4.5 Billion by the end of the ... Read More
-
NGS-Based RNA-Sequencing
... CAGR of 20.1% over the analysis period 2024-2030. Sequencing Platforms & Consumables, one of the segments analyzed in the report, is expected to record a 20.7% CAGR and reach US$5.1 Billion by the end of ... Read More
-
Clinical Oncology Next Generation Sequencing
... Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2024-2030. Whole Genome Sequencing, one of the segments analyzed in the report, is expected to record a 17.7% CAGR and reach US$733.2 ... Read More
-
Next Generation Sequencing (NGS) Data Analysis
... reach US$2.3 Billion by 2030, growing at a CAGR of 13.9% over the analysis period 2024-2030. Services, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$1.4 ... Read More
-
RNA Analysis / Transcriptomics
... 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$9.7 Billion by ... Read More
-
Spatial Genomics and Transcriptomics
... 2030, growing at a CAGR of 9.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$320.3 Million by the end ... Read More
-
Protein Sequencing
... CAGR of 2.9% over the analysis period 2024-2030. Mass Spectrometry, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$973.5 Million by the end of the analysis ... Read More
-
microRNA (miRNA)
... CAGR of 13.1% over the analysis period 2024-2030. Products, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$411.8 Million by the end of the analysis period. ... Read More
-
mRNA Platform
... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the analysis ... Read More
-
Next Generation Cancer Diagnostics
... 2030, growing at a CAGR of 21.8% over the analysis period 2024-2030. qPCR & Multiplexing, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$28.2 Billion by ... Read More
-
Whole Exome Sequencing
... at a CAGR of 20.2% over the analysis period 2024-2030. Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the end of the ... Read More
-
Next Generation Sequencing (NGS) Sample Preparation
... reach US$10.5 Billion by 2030, growing at a CAGR of 18.2% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 19.7% CAGR and ... Read More
-
Life Science Instrumentation Market, By Technology (Polymerase Chain Reaction, Next Generation Sequencing, Immunoassay, Flow Cytometry, Spectroscopy, Electrophoresis, Chromatography, Centrifuges, and Other Technologies), By End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organization, and Academia and Research Institutes), By Application (Clinical & Diagnostic, Research, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... and other clinical areas. Life science instrumentation is extensively used in pharmaceutical, biotechnology, clinical testing laboratories, and applied industries as well as in academic and research institutes. Some key types of life science instrumentation include ... Read More
-
Clinical Oncology Next Generation Sequencing Market Size, Share & Trends Analysis Report By Workflow (NGS Pre-sequencing, NGS Data Analysis), By Technology, By Application, By End Use, By Region, And Segment- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... the forecast period from 2024 to 2033. Key Takeaways: North America dominated the market in 2023 with a share of 49.68% The Asia Pacific region is expected to expand at the fastest CAGR of 17.4% ... Read More
-
Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Targeted Sequencing & Resequencing), By Product, By Application, By Workflow, By End-use, By Region And Segment- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
... period from 2024 to 2033. Key Takeaways: North America dominated the NGS market with a share of 49.35% in 2023. The Asia Pacific region is estimated to be the fastest growing region The oncology segment ... Read More
-
U.S. Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (Whole Exome Sequencing, Targeted Sequencing & Resequencing), By Product (Platforms, Consumables), By Application, By Workflow, By End-use, And Segment - Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033
... period from 2024 to 2033. Key Takeaways: The targeted sequencing and resequencing segment held the largest revenue share of 71.15% in 2023 and is expected to witness the fastest CAGR over the forecast period. The ... Read More
-
Innovative Medicine Market, By Therapy Type (Immunotherapy, Cell Therapy, Gene Therapy, Tissue Engineering, Small Molecule Therapy, Biologic Therapy, RNA-Based Therapy, Progenitor Cell Therapy, Peptide-Based Therapy, Microbiome Therapy, Antisense Oligonucleotide Therapy, CRISPR-based Therapy, mRNA-based Vaccines, and Monoclonal Antibodies), By Application (Oncology, Neurology, Cardiology, Ophthalmology, Dermatology, Musculoskeletal Disorders, Immunology & Inflammation, Genetic Disorders, Infectious Diseases, Metabolic Disorders, Hematology, Rare Diseases, Gastroenterology, and Others), By Route of Administration (Oral, Intravenous, Subcutaneous, Intramuscular, Topical, and Inhalation), By End User (Hospitals & Clinics, Academic & Research Institutes, Specialty Centers, Ambulatory Surgical Centers, Government & Regulatory Bodies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Innovative medicines, also known as specialty drugs or biopharmaceuticals, are advanced medical treatments that offer new and improved therapeutic options for various diseases. These medicines are developed using cutting-edge technologies and are designed to target ... Read More
-
Global Multiomics Market, By Product & Service (Products, Services), By Type (Single-cell Multiomics, Bulk Multiomics), By Platform (Genomics, Transcriptomics, Proteomics, Metabolomics, Integrated Omics Platforms), By Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, AgriGenomics, Others), By End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Clinical Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... facilitates a deeper understanding of molecular mechanisms, pathways, and networks compared to single-omics approaches. It allows researchers to gain a more complete picture of biological processes and phenotypes. The multiomics market is growing rapidly as ... Read More
Research Assistance
